Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma
Sign Up to like & getrecommendations! Published in 2025 at "Blood Advances"
DOI: 10.1182/bloodadvances.2025015973
Abstract: Key Points • BsAbs are safe and effective in frail and older patients with MM.• Advanced age, worse PS, and higher comorbidity burden do not predict inferior outcomes with BsAbs in myeloma. read more here.
Keywords: receiving bcma; bcma directed; directed bispecific; outcomes frail ... See more keywords